A Novel Insight to the Functional Role of Stathmin 1 in IgE-Mediated Activation of RBL-2H3 Cells
Abstract
IgE-mediated cell signaling, induced by cross-linking of high affinity receptor for IgE (FcεRI) in the presence of antigen (Ag), is a well known mechanism described for mast cell activation in allergy and hypersensitivity reactions, which induces a spectrum of cellular responses such as secretion and up-regulation of cell surface FcεRI. Although for several years IgE binding to FcεRI was considered to be a passive sensitization process, the outcomes of several recent studies have revealed a variety of different cellular responses to IgE binding compared to IgE plus Antigen binding.
The present study applied a functional proteomics-based approach to investigate mast cell signaling events and provided new insights to FcεRI-mediated cell signaling in RBL-2H3.1 cells, and may point to the activation of alternative signaling pathways in response to IgE or IgE plus Ag. Comparative analysis by 2-D PAGE of RBL cells activated with IgE plus Ag for three and four hours compared to non-activated cells was followed by mass spectrometric protein identification and provided evidence for the induction of Stathmin 1 (STMN1) gene expression in response to IgE plus Ag activation.
Complementary SDS-PAGE analysis showed a distinct up-regulation of STMN1 induction in response to challenge with IgE plus Ag compared to sensitization with IgE only. Phosphoproteomics analysis gave evidence for significant increase at phosphorylation of STMN1 on ser16 after 1min, though a slight rise at 5 min, and on ser38 after 1 and 5min sensitization with IgE and a similar result was observed for 1min IgE plus Ag-activation.
IgE plus Ag-activation was also found to induce the phosphorylation of ser38 to a greater extent than sensitization with IgE. In contrast, IgE alone was more effective than IgE plus Ag at inducing phosphorylation of ser16. Collectively this study provides further insights into the role of stathmin 1 in FcεRI-mediated activation of cells of mast cell lineage and might shed light on the diverse response of these cells to IgE or IgE plus Ag.
1. Rivera J, Fierro NA, Olivera A, Suzuki R. New Insights on Mast Cell Activation via the High Affinity Receptor for IgE1. Adv immunol 2008; 98:85-120.
2. Roth K, Chen WM, Lin TJ. Positive and negative regulatory mechanisms in high-affinity IgE receptor- mediated mast cell activation. Arch immunol ther exp(Waesz) 2008; 56(6):385-99.
3. Metcalfe DD, Peavy RD, Gilfillan AM. Mechanisms of mast cell signaling in anaphylaxis. J Allergy ClinImmunol 2009; 124(4):639-46.
4. Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, Carbone DP, et al. Regulation of mast cell survival by IgE. Immunity 2001; 14(6):791-800.
5. Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, Siraganian RP, et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001; 14(6):801-11.
6. Furuichi K, Rivera J, Isersky C. The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression. Proc Natl Acad Sci USA 1985; 82(5):1522-5.
7. Hsu C, MacGlashan D Jr. IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol lett 1996; 52(2-3):129-34.
8. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, et al. IgE enhances mouse mast cell Fc RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 185(4):663-72.
9. Tanaka S, Takasu Y, Mikura S, Satoh N, Ichikawa A.Antigen-independent induction of histamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J Exp Med 2002; 196(2):229-35.
10. Kitaura J, Song J, Tsai M, Asai K, Maeda-Yamamoto M, Mocsai A, et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the Fc RI. Proc Natl Acad Sci U S A 2003; 100(22):12911-6.
11. Yamada N, Matsushima H, Tagaya Y, Shimada S, Katz SI. Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells. J Invest Dermatol 2003; 121(6):1425-32.
12. Oka T, Hori M, Tanaka A, Matsuda H, Karaki H, Ozaki H. IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells. Am J Physiol Cell Physiol 2004; 286(2):C256-63.
13. Pandey V, Mihara S, Fensome-Green A, Bolsover S, Cockcroft S. Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca 2+, degranulation, and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol 2004;172(7):4048-58.
14. Lam V, Kalesnikoff J, Lee CWK, Hernandez-Hansen V, Wilson BS, Oliver JM, et al. IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE+ antigen but distinct from those used by Steel factor. Blood 2003; 102(4):1405-13.
15. Kawanishi H. Role of IgE as a mast cell development co- factor in the differentiation of murine gut-associated mast cells in vitro. Eur J Immunol 1986;
16(6):689-92. 16. Sobel A, Boutterin MC, Beretta L, Chneiweiss H, Doye V, Peyro-Saint-Paul H. Intracellular substrates for extracellular signaling. Characterization of a ubiquitous, neuron-enriched phosphoprotein (stathmin). J Biol Chem 1989; 264(7):3765-72.
17. Gavet O, Ozon S, Manceau V, Lawler S, Curmi P, Sobel A. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J Cell Sci 1998; 111(22):3333-46.
18. Rubin CI, Atweh GF. The role of stathmin in the regulation of the cell cycle. J cell biochem 2004;93(2):242-50.
19. Howell B, Deacon H, Cassimeris L. Decreasing oncoprotein 18/stathmin levels reduces microtubule catastrophes and increases microtubule polymer in vivo. J Cell Sci 1999; 112(21):3713-22.
20. Tobey RA, Valdez JG, Crissman HA. Synchronization of human diploid fibroblasts at multiple stages of the cell cycle. Exp Cell Res 1988; 179(2):400-16.
21. Hanash SM, Strahler JR, Kuick R, Chu EH, Nichols D.Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem 1988; 263(26):12813-15.
22. Cajone F, Sherbet GV. Stathmin is involved in S100A4- mediated regulation of cell cycle progression. Clin Exp Metastasis 1999; 17(10):865-71.
23. Slater A, Smallman LA, Drake-Lee AB. Increase in epithelial mast cell numbers in the nasal mucosa of patients with perennial allergic rhinitis. J Laryngol Otol 2007; 110(10):929-33.
24. Gibson PG, Allen CJ, Yang JP, Wong BJO, Dolovich J, Denburg J, et al. Intraepithelial mast cells in allergic and nonallergic asthma: assessment using bronchial brushings. The Am Rev Respir Dis 1993; 148(1):80-6.
25. Viegas M, Gomez E, Brooks J, Gatland D, Davies RJ.Effect of the pollen season on nasal mast cells. Br Med J 1987; 294(6569):414.
26. Strey CW, Spellman D, Stieber A, Gonatas JO, Wang X, Lambris JD, et al. Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am J Pathol 2004; 165(5):1701-18.
27. Smith AJ, Pfeiffer JR, Zhang J, Martinez AM, Griffiths GM, Wilson BS. Microtubule-dependent transport of secretory vesicles in RBL-2H3 cells. Traffic 2003;4(5):302-12.
28. Pasmantier R, Danoff ANN, Fleischer N, Schubart UK.P19, a hormonally regulated phosphoprotein of peptide hormone-producing cells: secretagogue-induced phosphorylation in AtT-20 mouse pituitary tumor cells and in rat and hamster insulinoma cells. Endocrinology 1986; 119(3):1229-38.
29. Watabe-Uchida M, John KA, Janas JA, Newey SE, Van Aelst L. The Rac activator DOCK7 regulates neuronal polarity through local phosphorylation of stathmin/Op18. Neuron 2006; 51(6):727-39.
30. Daub H, Gevaert K, Vandekerckhove J, Sobel A, Hall A.Rac/Cdc42 and p65PAK regulate the microtubule- destabilizing protein stathmin through phosphorylation at serine 16. J Biol Chem 2001; 276(3):1677-80.
31. Wacker I, Kaether C, Kromer A, Migala A, Almers W, Gerdes HH. Microtubule-dependent transport of secretory vesicles visualized in real time with a GFP-tagged secretory protein. J cell sci 1997; 110(13):1453-63.
32. Nishida K, Yamasaki S, Ito Y, Kabu K, Hattori K, Tezuka T, et al. Fc {varepsilon} RI-mediated mast cell degranulation requires calcium-independent microtubule- dependent translocation of granules to the plasma membrane. J Cell Biol 2005; 170(1):115-26.
33. Hayashi K, Pan Y, Shu H, Ohshima T, Kansy JW, White CL, et al. Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain. J Neurochem 2006; 99(1):237-50.
34. Leighton IA, Curmi P, Campbell DG, Cohen P, Sobel A.The phosphorylation of stathmin by MAP kinase. Mol cell Biochem 1993; 127(1):151-6.
35. Cassimeris L. The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 2002;14(1):18-24.
Files | ||
Issue | Vol 10, No 2 (2011) | |
Section | Articles | |
Keywords | ||
Fc epsilon RI Mast Cell RBL 2H3 Stathmin |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |